Science Explorer Back to mapMap
Discussion
Researcher · CRE Consulting (Poland) · Poland

Robert Plisko

Robert Plisko publishes mostly in Economics and Econometrics, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism, on topics such as Health Systems, Economic Evaluations, Quality of Life, Diabetes Treatment and Management and Pharmaceutical Economics and Policy.

OpenAlex
World rank
#5,302,068
of 7,710,434 ranked researchers
Rank in Poland
#46,594
of 100,960
Works
71
Citations
146
Citations per work
2.1
h-index
4
i10-index 2Top 79% in Economics and Econometrics
Robert Plisko

What does Robert Plisko research?

Robert Plisko's work is mostly in Medicine (31%), Economics, Econometrics and Finance (14%).

Everything else: 39 works · 55.5% of their workHealth Sciences: 22 works · 30.7% of their workMedicine: 22 works · 30.7% of their workPulmonary and Respiratory Medicine: 7 works · 9.4% of their workEndocrinology, Diabetes and Metabolism: 6 works · 8.1% of their workSurgery: 4 works · 5.6% of their workEpidemiology: 3 works · 3.8% of their workRheumatology: 3 works · 3.8% of their workSocial Sciences: 10 works · 13.8% of their workEconomics, Econometrics and Finance: 10 works · 13.8% of their workEconomics and Econometrics: 10 works · 13.8% of their workTHEIR WORKRobert Plisko71works
Health Sciences31%Social Sciences14%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else3955.5%
    1. Medicine2230.7%
    1. Economics, Econometrics and Finance1013.8%
  1. 1Economics and Econometrics14% of their works
  2. 2Pulmonary and Respiratory Medicine9% of their works
  3. 3Endocrinology, Diabetes and Metabolism8% of their works
  4. 4Surgery6% of their works
  5. 5Rheumatology4% of their works
  6. 6Epidemiology4% of their works

Research topics

Which keywords describe Robert Plisko's research?

The keywords of their largest research topics: Antiviral Therapy, Cost-effectiveness Analysis, Liver Disease, Quality of Life, Cardiovascular Outcomes, Drug Development Costs, Generic Drugs and Type 2 Diabetes.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Antiviral Therapy92 topics
  2. Cost-effectiveness Analysis91 topic
  3. Liver Disease92 topics
  4. Quality of Life91 topic
  5. Cardiovascular Outcomes61 topic
  6. Drug Development Costs61 topic
  7. Generic Drugs61 topic
  8. Type 2 Diabetes61 topic
  9. Cost of Care51 topic
  10. Financial Toxicity51 topic
  11. Hepatitis C Virus51 topic
  12. Treatment51 topic
  13. Chronic Hepatitis B41 topic
  14. Hepatitis B Virus41 topic
  15. Inhaler Devices41 topic
  16. Off-Label Drug Use41 topic
  17. Pediatric Pharmacokinetics41 topic
  18. Pulmonary Drug Delivery41 topic

Where does Robert Plisko work?

Robert Plisko's main affiliation in the publication record is CRE Consulting (Poland), Poland.

How many publications and citations does Robert Plisko have?

OpenAlex counts 71 works and 146 citations for Robert Plisko, an h-index of 4, ranking #5,302,068 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Robert Plisko. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.